PD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Domains and categories of needs in long-term follow-up of adult cancer survivors : a scoping review of systematic reviews | Healthcare |  | 2024 | 88 | 120 | ||
| Experiences and Needs of Swiss Cancer Survivors in the Domains of Health-Related Information and the Healthcare System | Cancers | | 2024 | 85 | 112 | ||
| Brain Metastases from Genito-Urinary Cancers in the Canton of Geneva (Switzerland) : Study of Incidence, Management and Outcomes | Cancers | | 2024 | 82 | 55 | ||
| Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study | Cancer | | 2024 | 157 | 92 | ||
| Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin | Haematologica | | 2024 | 98 | 73 | ||
| Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon : a retrospective study | Swiss medical weekly | | 2023 | 58 | 40 | ||
| Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics | International journal of cancer | | 2023 | 495 | 73 | ||
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | 2023 | 321 | 79 | ||
| Cancer vaccines | Cancer cell | | 2022 | 300 | 139 | ||
| Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer | BMC cancer | | 2022 | 251 | 104 | ||
| The probabilistic model of Alzheimer disease: the amyloid hypothesis revised | Nature reviews. Neuroscience |  | 2022 | 162 | 1 | ||
| Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer | iScience | | 2022 | 234 | 141 | ||
| Hyaline cartilage microtissues engineered from adult dedifferentiated chondrocytes: safety and role of WNT signaling | Stem cells translational medicine | | 2022 | 435 | 163 | ||
| Linking unfolded protein response to ovarian cancer cell fusion | BMC cancer | | 2022 | 276 | 170 | ||
| The first comprehensive genomic characterization of rectal squamous cell carcinoma | Journal of gastroenterology | | 2022 | 181 | 93 | ||
| Modeling poliovirus infection using human engineered neural tissue enriched with motor neuron derived from embryonic stem cells | Frontiers in Cell and Developmental Biology | | 2021 | 367 | 120 | ||
| SARS-CoV-2 Evolution among Oncological Population: In-Depth Virological Analysis of a Clinical Cohort | Microorganisms | | 2021 | 195 | 102 | ||
| Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy | Science Immunology | | 2021 | 455 | 933 | ||
| Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread | Neurology Genetics | | 2021 | 328 | 77 | ||
| Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer | Cancer Cell | | 2021 | 286 | 286 | ||
| Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin) | JCI insight | | 2021 | 258 | 107 | ||
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells | Communications Biology | | 2021 | 339 | 193 | ||
| Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm? | Cancer treatment reviews | | 2021 | 67 | 58 | ||
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | | 2020 | 434 | 174 | ||
| An experimentally defined hypoxia gene signature in glioblastoma and its modulation by metformin | Biology (Basel)[2079-7737] | | 2020 | 482 | 282 | ||
| Journée du cancer : mobiliser autour de la prévention | Revue médicale suisse | | 2020 | 233 | 131 | ||
| Immunologic clearance of a BK virus-associated metastatic renal allograft carcinoma | Transplantation | | 2020 | 341 | 271 | ||
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma | OncoImmunology | | 2020 | 456 | 268 | ||
| Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients | Frontiers in Oncology | | 2020 | 347 | 119 | ||
| Oncologie : naviguer la pandémie de COVID-19 et garder le cap | Revue médicale suisse | | 2020 | 255 | 108 | ||
| Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool | Health Science Reports | | 2020 | 210 | 173 | ||
| Une période de craintes et de défis : vers un monde meilleur ? | Revue médicale suisse | | 2020 | 206 | 0 | ||
| Stratégies de vaccination thérapeutique dans le glioblastome | Medecine Sciences | | 2020 | 210 | 350 | ||
| Resources-stratified guidelines for classical hodgkin lymphoma | International Journal of Environmental Research and Public Health | | 2020 | 409 | 241 | ||
| Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma | Cancers | | 2020 | 340 | 208 | ||
| Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma | Molecular and Cellular Proteomics | | 2019 | 431 | 2 | ||
| De sérieuses préoccupations qui ne cachent pas nos espoirs | Revue médicale suisse | | 2019 | 292 | 115 | ||
| Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients | Neuro-Oncology | | 2019 | 836 | 468 | ||
| Current strategies for vaccination in glioblastoma | Current Opinion in Oncology | | 2019 | 395 | 5 | ||
| Peptides as cancer vaccines | Current Opinion in Pharmacology | | 2019 | 423 | 4 | ||
| Actively personalized vaccination trial for newly diagnosed glioblastoma | Nature | | 2019 | 558 | 12 | ||
| Exploratory study of the effect of IMA950/poly-ICLC vaccination on response to bevacizumab in relapsing high-grade glioma patients | Cancers | | 2019 | 366 | 174 | ||
| Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma | Scientific Reports | | 2019 | 270 | 813 | ||
| Prophylactic Cranial Irradiation in Stage III Non-Small-Cell Lung Cancer: Overall Survival Should Not Necessarily Be the Final End Point | Journal of Clinical Oncology | | 2018 | 499 | 1 | ||
| CAR T-Cell Therapies in Glioblastoma: A First Look | Clinical Cancer Research | | 2018 | 591 | 2 | ||
| Onco-sexologie : un regard au cœur des patients | Revue médicale suisse | | 2018 | 291 | 134 | ||
| De vrais espoirs et de sérieuses préoccupations | Revue médicale suisse | | 2018 | 331 | 2 | ||
| Learning from the past to design better trials in second-line treatment for mesothelioma patients | Ecancermedicalscience | | 2018 | 357 | 118 | ||
| Médecine sexuelle et cancers : une main tendue vers l'humain | Revue médicale suisse | | 2018 | 366 | 183 | ||
| Diagnosis and treatment of follicular lymphoma: an update | Swiss Medical Weekly | | 2018 | 602 | 358 | ||
| Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors | The Journal of Pathology | | 2018 | 885 | 6 | ||
| Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma | Molecular and Cellular Proteomics | | 2018 | 436 | 2 | ||
| Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models | OncoImmunology | | 2018 | 429 | 1 | ||
| Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists | Canadian Journal of Cardiology | | 2018 | 530 | 2 | ||
| « Docteur, je jeûne lors de la chimiothérapie » : illusion ou nouvelle réalité clinique ? | Revue médicale suisse | | 2018 | 627 | 512 | ||
| Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland | Swiss Medical Weekly | | 2018 | 620 | 203 | ||
| Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma | OncoImmunology | | 2018 | 662 | 325 | ||
| Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy | Nutrition and Cancer | | 2018 | 480 | 430 | ||
| Prise en charge de la sexualité chez les patients oncologiques: Un projet de recherche au sein des Hôpitaux universitaires de Genève | Revue médicale suisse | | 2018 | 400 | 259 | ||
| BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma | Neurology | | 2017 | 544 | 201 | ||
| First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies | OncoImmunology | | 2017 | 649 | 9 | ||
| A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cells | Oncotarget | | 2017 | 531 | 183 | ||
| Les cancers s'envolent, les progrès suivent | Tribune de Geneve | | 2017 | 380 | 65 | ||
| Immunothérapie des gliomes : illusion ou espoir ? | Bulletin du cancer | 2017 | 421 | 0 | |||
| Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancer | Digestive and Liver Disease | | 2017 | 523 | 0 | ||
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial | The Lancet Oncology | | 2017 | 420 | 1 | ||
| Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports | | 2017 | 591 | 4 | ||
| ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells | EMBO Journal | | 2017 | 619 | 10 | ||
| 8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016 | Drug Metabolism and Personalized Therapy | | 2017 | 574 | 3 | ||
| Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients | British Journal of Haematology | | 2017 | 455 | 0 | ||
| Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma | Cancer Cell | | 2017 | 513 | 5 | ||
| L'accès à l'innovation | Revue médicale suisse | | 2017 | 339 | 0 | ||
| Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? | Frontiers in Oncology | | 2016 | 527 | 408 | ||
| Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressiveness | Biomaterials | | 2016 | 559 | 5 | ||
| Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes | Journal of neuro-oncology | | 2016 | 518 | 437 | ||
| Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysis | Cancer medicine | | 2016 | 576 | 185 | ||
| Cell-penetrating peptides-the Swiss Army knife of cancer vaccines | Oncoimmunology | | 2016 | 644 | 294 | ||
| Progrès dans l'immunothérapie des tumeurs cérébrales : difficultés et perspectives | Revue médicale suisse | | 2016 | 343 | 2 | ||
| Medulloblastoma in children and adults: one distinct disease entity? | Bulletin suisse du cancer | | 2016 | 499 | 58 | ||
| Hypoxia and antitumor CD8(+) T cells: An incompatible alliance? | OncoImmunology | | 2016 | 485 | 319 | ||
| Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing | PloS one | | 2016 | 666 | 609 | ||
| Ipilimumab-related hypophysitis may precede severe CNS immune attack | Annals of Oncology | | 2016 | 455 | 0 | ||
| Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants | Molecular therapy | | 2016 | 676 | 319 | ||
| Chimiothérapie de maintenance : futile ou utile ? | Revue médicale suisse | | 2015 | 474 | 186 | ||
| Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit | Supportive care in cancer | | 2015 | 680 | 1 | ||
| Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells | European Journal of Immunology | | 2015 | 550 | 7 | ||
| Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review | CNS oncology | 2015 | 504 | 0 | |||
| Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity | Cancer research | | 2015 | 642 | 10 | ||
| La société face au cancer : prises de conscience et initiatives citoyennes | Revue médicale suisse | | 2015 | 379 | 70 | ||
| Lymphome cérébral : une présentation classique ? | Revue médicale suisse | | 2015 | 393 | 461 | ||
| Immunotherapy of Brain Tumors | Progress in tumor research | 2015 | 583 | 0 | |||
| Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome | Annals of oncology | | 2015 | 479 | 178 | ||
| Création du Centre du cancer de la prostate des HUG | Revue médicale suisse | | 2014 | 752 | 2 | ||
| Immunotherapy for glioma: from illusion to realistic prospects? | American Society of Clinical Oncology educational book | | 2014 | 1,270 | 601 | ||
| Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma | British journal of cancer | | 2014 | 662 | 171 | ||
| Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response | International journal of cancer | | 2014 | 746 | 405 | ||
| Extrachromosomal driver mutations in glioblastoma and low-grade glioma | Nature communications | | 2014 | 763 | 219 | ||
| Fine-needle aspiration biopsy for the diagnosis of metastatic type B thymoma to lymph nodes: A case report | Diagnostic cytopathology | | 2014 | 620 | 0 | ||
| Injecting hope into brain cancer treatment: is immunotherapy the way forward? | CNS Oncology | | 2014 | 401 | 0 | ||
| Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) | European urology | | 2013 | 593 | 0 | ||
| Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients | Clinical & developmental immunology | | 2013 | 640 | 561 | ||
| Neuropathies associées aux paraprotéinémies (gammapathies monoclonales) | Revue médicale suisse | | 2013 | 446 | 0 | ||
| Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours | PloS one | | 2013 | 721 | 318 | ||
| The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma | Biomaterials | | 2013 | 726 | 6 | ||
| Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy | Journal of neuro-oncology | | 2013 | 680 | 0 | ||
| Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies | Immunotherapy |  | 2013 | 542 | 0 | ||
| Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival | Nature medicine | | 2012 | 577 | 2 | ||
| MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status | Acta neuropathologica | | 2012 | 602 | 1,037 | ||
| Plasmablastic lymphoma clinically presenting in the urinary tract | Annals of diagnostic pathology | | 2012 | 665 | 0 | ||
| A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma | Haematologica | | 2012 | 633 | 453 | ||
| Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy | Brain | | 2012 | 702 | 1,372 | ||
| Complete remission with tyrosine kinase inhibitors in renal cell carcinoma | Journal of clinical oncology | | 2012 | 755 | 779 | ||
| Visceral Kaposi's Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient: Case Report and Literature Review | Case reports in oncological medicine | | 2012 | 633 | 299 | ||
| Takotsubo syndrome secondary to adrenal adenocarcinoma: cortisol as a possible culprit | American journal of respiratory and critical care medicine | | 2012 | 655 | 5 | ||
| A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients | The oncologist | | 2012 | 687 | 0 | ||
| Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis | Case reports in oncology | | 2011 | 653 | 0 | ||
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | | 2011 | 1,043 | 595 | ||
| Soin nutritionnel intégré au soin oncologique : un besoin d'optimisation | Revue médicale suisse | | 2011 | 978 | 796 | ||
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | | 2011 | 867 | 8 | ||
| Prevention of CNS relapse in diffuse large B-cell lymphoma | Lancet oncology | | 2011 | 563 | 0 | ||
| Recurrent Syncope due to Esophageal Squamous Cell Carcinoma | Case reports in oncology | | 2011 | 689 | 282 | ||
| Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case report | Journal of medical case reports | | 2011 | 618 | 165 | ||
| Oncology ESAB 2011 | | 2011 | 674 | 10 | |||
| Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma | GLIA | | 2010 | 681 | 0 | ||
| Marker-independent identification of glioma-initiating cells | Nature methods | | 2010 | 535 | 0 | ||
| Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98 | Journal of clinical oncology | | 2010 | 547 | 0 | ||
| Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development | Cancer research | | 2010 | 614 | 3 | ||
| T-cell immunotherapy for malignant glioma: toward a combined approach | Current opinion in oncology | | 2010 | 661 | 2 | ||
| Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma | Journal of clinical oncology | | 2010 | 621 | 0 | ||
| Tumors that look for their springtime in APRIL | Critical reviews in oncology/hematology | | 2009 | 656 | 0 | ||
| Limits of CD133 as a marker of glioma self-renewing cells | International journal of cancer | | 2009 | 639 | 0 | ||
| Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant | Journal of immunotherapy | | 2009 | 613 | 0 | ||
| Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital | British journal of cancer | | 2009 | 695 | 0 | ||
| Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error? | Blood | | 2009 | 543 | 1 | ||
| Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva) | Dermatology | | 2008 | 539 | 0 | ||
| Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma | Journal of clinical oncology | | 2008 | 692 | 0 | ||
| Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants : résultats préliminaires d'une étude multicentrique de l'Anocef | Revue neurologique | 2008 | 679 | 0 | |||
| Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome | Annals of oncology | | 2008 | 589 | 0 | ||
| Percutaneous cementoplasty in multiple myeloma: a valuable adjunct for pain control and ambulation maintenance | Supportive care in cancer | | 2008 | 643 | 275 | ||
| Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes | GLIA | | 2008 | 653 | 11 | ||
| Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers | Annals of oncology | | 2008 | 536 | 0 | ||
| Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system | World journal of surgical oncology | | 2008 | 1,175 | 534 | ||
| Bortezomib-induced skin eruption | Dermatology | | 2008 | 595 | 0 | ||
| Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas | Journal of pathology | | 2006 | 643 | 0 | ||
| Cytomegalovirus colitis--a severe complication after standard chemotherapy | Acta oncologica | | 2002 | 620 | 0 |
